GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Mitesco MITI · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.02

-15.25%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$38,700

FY2016FY2025

Net income

$498,724

FY2016FY2025

Free cash flow

−$701,590

FY2016FY2025

Shareholders' equity

−$23.5m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$38,700$43,700$690,534$690,534$115,994—$3,500———
Research and development$81,717—————————
Operating income−$1.8m−$1.2m−$2.6m−$10.6m−$6.4m−$2.5m−$1.4m−$1.3m−$699,957−$4.4m
Net income$498,724−$2.5m−$13.3m−$23.2m−$7.9m−$2.9m−$3.9m−$1.4m−$754,045−$4.9m
Diluted earnings per share0.03-0.37-2.50-5.02-0.04-1.36-0.05-2.82-2.14-18.48

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$132,108$189,841$2,838$2.6m$10.7m$798,514$100,820$3,804—$1,875
Cash and short-term investments$100,857$3,402$2,838—$1.2m$64,789$83,245$1,304——
Total liabilities$23.6m$26.6m$14.1m$21.7m$9.5m$3.3m$2.4m$1.7m$1.4m$1.1m
Debt$1.6m$1.1m$1.8m—$5.2m$1.2m$199,278$671,860$422,336$256,270
Shareholders' equity−$23.5m−$26.4m−$14.1m−$19.1m$1.1m−$2.5m−$2.3m−$1.7m−$1.4m−$1.1m
Shares outstanding15m7m5m5m213m2m81m1m0m0m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$701,585−$514,409−$759,730−$5.2m−$5.0m−$1.5m−$784,469−$246,932−$47,000−$269,508
Capital spending−$5—−$1.7m−$1.7m−$1.9m−$1.9m−$7,854−$7,854−$7,854—
Free cash flow−$701,590−$514,409−$2.5m−$6.9m−$6.9m−$3.4m−$792,323−$254,786−$54,854−$269,508
Dividends paid—————−$65,568————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$20,000——$3,000$18,700$17,000$14,200$23,500
Operating income−$458,872−$352,929−$134,850−$1.0m−$351,754−$267,000−$472,000−$216,000
Net income−$977,384−$777,289$338,743−$3.2m−$87,384$3.5m−$4.2m$2.1m
Diluted earnings per share-0.05-0.040.02-0.21-0.010.23-0.630.31
Total assets$101,525$31,429$132,108$165,692$170,678$189,586$189,841$61,322
Cash and short-term investments$7,984$1,533—$321$2,724$189$3,402$31,822
Debt$13.4m$1.7m—$1.1m$735,620$1.1m$1.1m$1.7m
Shareholders' equity−$24.3m−$23.9m−$23.5m−$23.8m−$22.1m−$22.2m−$26.4m−$12.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-61.7%——
Operating income-45.0%-7.0%39.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-3554.6%-1100.4%——
Net margin-2443.3%-2636.3%——

Valuation history

At each fiscal year end

FY2025FY2024FY2021FY2019
Price to earnings3.3-0.5——
Price to sales42.228.90.10.4

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-53%138540%1168%-83%650%-50%-64%0%515%-31%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 50-to-1 reverse split · 12 Dec 2022
  • 101-to-1 reverse split · 20 Jan 2016
  • 40-to-1 reverse split · 13 Jan 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.